发明名称 Pulsatile release histamine H2 antagonist dosage form
摘要 A unit dosage form, such as a capsule or the like, for delivering drugs into the body in a circadian release fashion comprising one or more populations of drug-containing particles (beads, pellets, granules, etc.) is disclosed. Each bead population exhibits a pre-designed rapid or sustained release profile with or without a predetermined lag time of 3 to 5 hours. Such a circadian rhythm release drug delivery system is designed to provide a plasma concentration-time profile, which varies according to physiological need at different times during the dosing period, i.e., mimicking the circadian rhythm and severity/manifestation of gastric acid secretion (and/or midnight gerd), predicted based on pharmaco-kinetic and pharmaco-dynamic considerations and in vitro/in vivo correlations.
申请公布号 US6663888(B2) 申请公布日期 2003.12.16
申请号 US20020057759 申请日期 2002.01.25
申请人 EURAND PHARMACEUTICALS LTD. 发明人 PERCEL PHILIP J.;VYAS NEHAL H.;VISHNUPAD KRISHNA S.;VENKATESH GOPI M.
分类号 A61K9/26;A61K9/50;A61K9/52;A61K9/54;A61K9/60;(IPC1-7):A61K9/52 主分类号 A61K9/26
代理机构 代理人
主权项
地址